- Home
- RKTO vs DUKR Comparison
RKTO vs DUKR Comparison
Compare RKTO & DUKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.53
N/A
Current Price
$4.15
Company Overview
Basic Information| Metric | RKTO | DUKR |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 20.1M |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | RKTO | DUKR |
|---|---|---|
| Price | $0.53 | $4.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 247.2K | 10.3K |
| Earning Date | 11-11-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.69 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $377,000.00 |
| Revenue This Year | N/A | $430.50 |
| Revenue Next Year | N/A | $245.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 249.07 |
| 52 Week Low | $0.48 | $3.90 |
| 52 Week High | $1.19 | $7.41 |
Technical Indicators
Market Signals| Indicator | RKTO | DUKR |
|---|---|---|
| Relative Strength Index (RSI) | 32.20 | 30.85 |
| Support Level | N/A | $3.90 |
| Resistance Level | $0.77 | $5.85 |
| Average True Range (ATR) | 0.05 | 0.46 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 17.19 | 16.03 |
Price Performance
Historical Comparison RKTO
DUKR
About RKTO Rocket One Inc. Common Stock
Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The company also intends to pursue opportunities related to nano-launch systems and nanosatellite deployment. In addition, its biotechnology operations, conducted through a wholly owned subsidiary, include development programs such as HT-001, HT-KIT, HT-ALZ, and a GDNF-based metabolic program.